Because Ozempic affects digestion and metabolic regulation, it may interact with certain other medications
The approval by the FDA also clears the pill for usage to reduce the risk of major cardiovascular events like death, heart attack, or stroke in adults having obesity and established cardiovascular disease, says Novo Nordisk
IGF-1 signaling is frequently evaluated in relation to muscle metabolism, tissue turnover, recovery signaling, and body composition research
The FDA has approved these agents for type 2 diabetes management (not type 1 diabetes or diabetic ketoacidosis), with select formulations also approved for chronic weight management in adults with obesity or overweight with weight-related comorbidities
Exercise by Atherosclerotic Cardiovascular Disease Status A JACC Data Report on Trends in the United States, 2020-2024